Immune-related adverse events (IrAEs) as a predictor of response to immunotherapy in patients with lung cancer

被引：0
|
作者：
Sanchez Becerra, M. V. [1 ]
Martinez-Cabanes, R. [1 ]
Gonzalez-Lopez, A. [1 ]
Zhan-Zhou, E. [2 ]
Sotelo, V. [1 ]
Esteban, M. [1 ]
Robles, T. [1 ]
Camara, J. C. [1 ]
Cardena, A. [1 ]
Hernando, S. [1 ]
Hurtado, A. [2 ]
Moreno, D. [1 ]
Olier, C. [1 ]
Mielgo Rubio, X. [1 ]
机构：
[1] Hosp Univ Fdn Alcorcon, Med Oncol, Alcorcon, Spain
[2] Hosp Univ Fdn Alcorcon, Alcorcon, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
204P
引用
收藏
页码：S808 / S809
页数：2
相关论文
共 50 条
  • [41] Management of immune-related adverse events (irAEs) - what needs to be respected?
    Thomssen, Christoph
    GYNAKOLOGE, 2022, 55 (05): : 344 - 350
  • [42] Rare Immune-Related Adverse Events (irAEs): Approach to Diagnosis and Management
    Javaid, Anadil
    Bennett, Catherine
    Rao, Aparna
    Spain, Lavinia
    PHARMACEUTICAL MEDICINE, 2024, 38 (01) : 25 - 38
  • [43] Rare Immune-Related Adverse Events (irAEs): Approach to Diagnosis and Management
    Anadil Javaid
    Catherine Bennett
    Aparna Rao
    Lavinia Spain
    Pharmaceutical Medicine, 2024, 38 : 25 - 38
  • [44] Immune-Related Adverse Events (irAEs): Diagnosis, Management, and Clinical Pearls
    Eli P. Darnell
    Meghan J. Mooradian
    Erez N. Baruch
    Melis Yilmaz
    Kerry L. Reynolds
    Current Oncology Reports, 2020, 22
  • [45] Immune-Related Adverse Events (irAEs): Diagnosis, Management, and Clinical Pearls
    Darnell, Eli P.
    Mooradian, Meghan J.
    Baruch, Erez N.
    Yilmaz, Melis
    Reynolds, Kerry L.
    CURRENT ONCOLOGY REPORTS, 2020, 22 (04)
  • [46] Review of Immune-Related Adverse Events (irAEs) in Non-Small-Cell Lung Cancer (NSCLC)-Their Incidence, Management, Multiorgan irAEs, and Rechallenge
    Vaddepally, Raju
    Doddamani, Rajiv
    Sodavarapu, Soujanya
    Madam, Narasa Raju
    Katkar, Rujuta
    Kutadi, Anupama P.
    Mathew, Nibu
    Garje, Rohan
    Chandra, Abhinav B.
    BIOMEDICINES, 2022, 10 (04)
  • [47] Response criteria for immunotherapy and the radiologic patterns of immune-related adverse events
    Elsherif, Sherif B.
    Anderson, Marcus
    Chaudhry, Ammar A.
    Kumar, Sindhu P.
    Gopireddy, Dheeraj R.
    Lall, Chandana
    Bhosale, Priya R.
    EUROPEAN JOURNAL OF RADIOLOGY, 2022, 146
  • [48] Association between immune-related adverse events (irAEs) and clinical outcomes (CO) in advanced urothelial cancer patients (pts) treated with immunotherapy (IO).
    Shabto, Julie M.
    Martini, Dylan J.
    Liu, Yuan
    Ravindranathan, Deepak
    Kline, Meredith R.
    Hitron, Elise
    Russler, Greta
    Caulfield, Sarah
    Kissick, Haydn
    Alemozaffar, Mehrdad
    Ogan, Kenneth
    Harris, Wayne
    Master, Viraj A.
    Carthon, Bradley Curtis
    Kucuk, Omer
    Bilen, Mehmet Asim
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [49] Safety of Immunotherapy Rechallenge After Immune-related Adverse Events in Patients With Advanced Cancer
    Kartolo, Adi
    Holstead, Ryan
    Khalid, Sidra
    Emack, Jeffrey
    Hopman, Wilma
    Baetz, Tara
    JOURNAL OF IMMUNOTHERAPY, 2021, 44 (01) : 41 - 48
  • [50] Association of antibiotic treatment with immune-related adverse events in patients with cancer receiving immunotherapy
    Jing, Ying
    Chen, Xue
    Li, Kunyan
    Liu, Yaoming
    Zhang, Zhao
    Chen, Yiqing
    Liu, Yuan
    Wang, Yushu
    Lin, Steven H.
    Diao, Lixia
    Wang, Jing
    Lou, Yanyan
    Johnson, Douglas B.
    Chen, Xiang
    Liu, Hong
    Han, Leng
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (01)
12345